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The establishment of European Reference Networks as
laid out under the Cross Border Health Care Directive
(CBHCD) is a major opportunity for the rare disease com-
munity. There have been many successful networks for
rare disease groups, but their establishment has been ad
hoc and funding streams variable. Sustainability has been
a major challenge. Although the assessment of the quality
of these networks has not been systematic, nonetheless
networks have succeeded in establishing important infra-
structure including disease specific registries, shared tools
such as tele-expertise and the production of disease speci-
fic guidelines and training pathways.
Within the CBHCD it is envisaged that European
Reference networks will be established, and these will not
only relate to rare diseases. These networks will primarily
link nationally designated centres of expertise. Within
the EUCERD a process is being followed to inform the
CBHCD committee on the specific issues relating to
ERNs for rare diseases. These recommendations relate to
areas of designation and governance, capacity building
and resources to support ERNs and quality assurance.
The recommendations will be discussed in a series of
meetings in 2012, with the aim of producing a EUCERD
recommendation on ERNs for rare diseases by the end of
the year in line with the timeline of the cross border
health care directive.
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